Biotest Pharmaceuticals Corporation Announces the Opening of its Newest Plasma Collection Facility in Clemson, South Carolina

BOCA RATON, Florida, July 26, 2016  – Biotest Pharmaceuticals Corporation (BPC), a leading manufacturer of immunological biotherapeutic products, is pleased to announce the addition of its newest plasma collection center located at  500 Old Greenville Hwy, Clemson, South Carolina. The 15,400  square foot state-of-the-art facility officially  opened its doors for business on July 25, 2016 and brings the total number of BPC’s plasma collection centers to twenty.

“The opening of our 20th  center further reinforces our continued commitment to the expansion of our existing network of plasma collection centers. We are fully dedicated to better serve the thousands of patients worldwide who rely on plasma- based therapies,” said Ileana Carlisle, BPC’s Chief Executive Officer.

BPC has invested approximately $2.0 million in the construction of this facility. The Company expects to add over forty jobs to the Clemson’s local economy and currently has employment opportunities available for medical personnel and phleboomists.

In addition to supporting the local economy through employment opportunities, the Clemson Biotest Plasma Center is actively recruiting local residents to donate plasma. Plasma donors not only contribute the source material for these plasma-derived therapies which save the lives of thousands of patients but are also compensated for their donations.

About Biotest Pharmaceuticals Corporation

Biotest Pharmaceuticals is a wholly-owned subsidiary of Biotest AG, a German global provider of plasma products. The Company researches, develops and manufactures biotherapeutic plasma protein products, with a specialization in immunology and hematology and is a leader in the collection of source plasma. Biotest Pharmaceuticals owns and manages plasmapheresis centers across the United States and operates a state-of-the-art manufacturing facility in Boca Raton, Florida. We are committed to serving the thousands of patients worldwide who rely on plasma-based therapies

Biotest Pharmaceuticals’ team of over 1000 employees is part of Biotest AG’s global workforce of more than 2,300 associates worldwide. To learn more about Biotest Pharmaceuticals, our Plasma Centers, and the difference we make in the lives of patients and the healthcare community, please visit us at  www.biotestpharma.com  and  www.biotestplasma.com.

Contact:  media@biotestpharma.com